Literature DB >> 8408579

False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis.

B P Currie1, L F Freundlich, M A Soto, A Casadevall.   

Abstract

Three cases of false-negative cerebrospinal fluid latex agglutination test results for patients with culture-positive cryptococcal meningitis are reported. False-negative results occurred in settings of low cryptococcal antigen concentrations in cerebrospinal fluid and were dependent on the latex agglutination test kit used. Investigation of each case revealed that prozone phenomena or interference from bound antibody or protein could not account for the false-negative results.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408579      PMCID: PMC265794          DOI: 10.1128/jcm.31.9.2519-2522.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  DETECTION OF CRYPTOCOCCAL POLYSACCHARIDE IN SERUM AND SPINAL FLUID: VALUE IN DIAGNOSIS AND PROGNOSIS.

Authors:  J E BENNETT; H F HASENCLEVER; B S TYNES
Journal:  Trans Assoc Am Physicians       Date:  1964

2.  Experience with the use of pronase to eliminate interference factors in the latex agglutination test for cryptococcal antigen.

Authors:  L D Gray; G D Roberts
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

3.  Diagnosis of cryptococcal meningitis. Value of immunologic detection of cryptococcal antigen.

Authors:  J S Goodman; L Kaufman; M G Koenig
Journal:  N Engl J Med       Date:  1971-08-19       Impact factor: 91.245

4.  New cause for false-positive results with the cryptococcal antigen test by latex agglutination.

Authors:  W H Boom; D J Piper; K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

5.  False-negative cryptococcal antigen test.

Authors:  A M Stamm; S S Polt
Journal:  JAMA       Date:  1980-09-19       Impact factor: 56.272

6.  Cryptococcal antigen test.

Authors:  M A Gordon
Journal:  JAMA       Date:  1981-09-25       Impact factor: 56.272

7.  Postzone v prozone.

Authors:  T W Stewart; D Parnell
Journal:  JAMA       Date:  1982-08-13       Impact factor: 56.272

8.  False-positive reactions in the latex agglutination test for Cryptococcus neoformans antigen.

Authors:  J S Heelan; L Corpus; N Kessimian
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

9.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

Review 10.  Cryptococcosis.

Authors:  J R Perfect
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

View more
  18 in total

1.  Immunoreactivity of cryptococcal antigen is not stable under prolonged incubations in human serum.

Authors:  Diane C McFadden; Oscar Zaragoza; Arturo Casadevall
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies.

Authors:  S Mukherjee; A Casadevall
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

3.  Cryptosporidium antigen detection in human feces by reverse passive hemagglutination assay.

Authors:  S C Arya
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

4.  In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.

Authors:  W Cleare; R Cherniak; A Casadevall
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 5.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 6.  Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

Authors:  T G Mitchell; J R Perfect
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Comparison of Antigen Detection and Nested PCR in CSF Samples of HIV Positive and Negative Patients with Suspected Cryptococcal Meningitis in a Tertiary Care Hospital.

Authors:  Sunita Kumari; Rajesh Kumar Verma; Dharmendra Prasad Singh; Ramakant Yadav
Journal:  J Clin Diagn Res       Date:  2016-04-01

8.  Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1.

Authors:  F Chen; B P Currie; L C Chen; S G Spitzer; E D Spitzer; A Casadevall
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

9.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

10.  Elimination of false-positive serum reactivity in latex agglutination test for cryptococcal antigen in human immunodeficiency virus-infected population.

Authors:  S Whittier; R L Hopfer; P Gilligan
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.